{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:02:42Z","timestamp":1789016562254,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic microangiopathy was clearly identified in sickle cell disease (SCD) using fluorescein angiography. A prospective observational clinical study was conducted to assess the foveal avascular zone (FAZ) area and explore perifoveal microvasculature changes in the superficial (SCP) and deep (DCP) capillary plexus using optical coherence tomography angiography (OCTA) and compare two genotypes\u2014HbS\/HbS (HbSS) and HbS\/HbC (HbSC)-to control. All consecutive patients with electrophoretic confirmation of SCD were included. Swept-source OCTA scans (Triton Plus, Topcon, Tokyo, Japan) with a 3\u2009\u00d7\u20093-mm scanning area and ultra-wide field (UWF) retinography (California, Optos, Fife, Scotland) were recorded for all patients. For OCTA analysis, preset parameters were used to segment the SCP and DCP. The FAZ area was manually assessed. The number of vascular branching points was automatically assessed based on the vascular skeletonization using ImageJ software. Eyes were staged based on Goldberg\u2019s classification of SCD retinopathy (SCDR) using UWF imaging. Forty-six eyes of 24 patients were included in the HbSS (n\u2009=\u200927) and HbSC (n\u2009=\u200919) groups and 16 eyes of 8 unaffected patients in a control group. In the DCP, the FAZ was significantly larger in the HbSC (p\u2009=\u20090.0001) and HbSS (p\u2009=\u20090.0004) groups compared to controls. The FAZ area in the SCP, CRT and number of superficial vascular branching points did not significantly differ between both genotypes. There were less branching points in the HbSC (p\u2009=\u20090.034) and HbSS (p\u2009=\u20090.0014) groups than in controls. The Goldberg stage was significantly higher in the HbSC group than in the HbSS group (2.21 vs. 1.22, p\u2009=\u20090.0062). OCTA provides useful information on macular microvasculature and structural alterations associated with SCDR. Ischemic abnormalities are more predominant in the DCP in case of SCDR and no difference was found between genotypes of patients visually asymptomatic.<\/jats:p>","DOI":"10.1038\/s41598-020-68625-8","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:02:53Z","timestamp":1594893773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Analysis of the foveal microvasculature in sickle cell disease using swept-source optical coherence tomography angiography"],"prefix":"10.1038","volume":"10","author":[{"given":"A.","family":"Mokrane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gazeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fajnkuchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Giocanti-Aur\u00e9gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"68625_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","volume":"364","author":"MJ Stuart","year":"2004","unstructured":"Stuart, M. J. & Nagel, R. L. Sickle-cell disease. Lancet Lond. Engl. 364, 1343\u20131360 (2004).","journal-title":"Lancet Lond. Engl."},{"key":"68625_CR2","doi-asserted-by":"crossref","unstructured":"Emerson, G.G., et al. Hemoglobinopathies A2. In (eds. Ryan, S.J., Hinton, D.R., et al.) 1429\u20131445 (2006).","DOI":"10.1016\/B978-0-323-02598-0.50085-9"},{"key":"68625_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/112067210801800213","volume":"18","author":"D Sayag","year":"2008","unstructured":"Sayag, D. et al. Retinal photocoagulation for proliferative sickle cell retinopathy: A prospective clinical trial with new sea fan classification. Eur. J. Ophthalmol. 18, 248\u2013254 (2008).","journal-title":"Eur. J. Ophthalmol."},{"key":"68625_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0002-9394(73)90892-1","volume":"75","author":"I Acacio","year":"1973","unstructured":"Acacio, I. & Goldberg, M. F. Peripapillary and macular vessel occlusions in sickle cell anemia. Am. J. Ophthalmol. 75, 861\u2013866 (1973).","journal-title":"Am. J. Ophthalmol."},{"key":"68625_CR5","first-page":"OP652","volume":"77","author":"N Romayanada","year":"1973","unstructured":"Romayanada, N., Goldberg, M. F. & Green, W. R. Histopathology of sickle cell retinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 77, OP652-676 (1973).","journal-title":"Trans. Am. Acad. Ophthalmol. Otolaryngol."},{"key":"68625_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/bjo.60.6.431","volume":"60","author":"GK Asdourian","year":"1976","unstructured":"Asdourian, G. K. et al. Macular and perimacular vascular remodelling sickling haemoglobinopathies. Br. J. Ophthalmol. 60, 431\u2013453 (1976).","journal-title":"Br. J. Ophthalmol."},{"issue":"92","key":"68625_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archopht.1974.01010010469002","volume":"1960","author":"TS Stevens","year":"1974","unstructured":"Stevens, T. S. et al. Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. Arch. Ophthalmol. Chic. Ill 1960(92), 455\u2013463 (1974).","journal-title":"Arch. Ophthalmol. Chic. Ill"},{"key":"68625_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajo.2015.12.023","volume":"164","author":"W Minvielle","year":"2016","unstructured":"Minvielle, W. et al. Macular microangiopathy in sickle cell disease using optical coherence tomography angiography. Am. J. Ophthalmol. 164, 137-144.e1 (2016).","journal-title":"Am. J. Ophthalmol."},{"issue":"Suppl 1","key":"68625_CR9","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1097\/IAE.0000000000001230","volume":"36","author":"KG Falavarjani","year":"2016","unstructured":"Falavarjani, K. G. et al. Correlation of multimodal imaging in sickle cell retinopathy. Retina Phila. Pa 36(Suppl 1), S111\u2013S117 (2016).","journal-title":"Retina Phila. Pa"},{"key":"68625_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/jamaophthalmol.2015.2824","volume":"133","author":"IC Han","year":"2015","unstructured":"Han, I. C., Tadarati, M. & Scott, A. W. Macular vascular abnormalities identified by optical coherence tomographic angiography in patients with sickle cell disease. JAMA Ophthalmol. 133, 1337\u20131340 (2015).","journal-title":"JAMA Ophthalmol."},{"key":"68625_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.02.007","volume":"177","author":"IC Han","year":"2017","unstructured":"Han, I. C., Tadarati, M., Pacheco, K. D. & Scott, A. W. Evaluation of macular vascular abnormalities identified by optical coherence tomography angiography in sickle cell disease. Am. J. Ophthalmol. 177, 90\u201399 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"68625_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bjo.74.3.172","volume":"74","author":"PD Fox","year":"1990","unstructured":"Fox, P. D., Dunn, D. T., Morris, J. S. & Serjeant, G. R. Risk factors for proliferative sickle retinopathy. Br. J. Ophthalmol. 74, 172\u2013176 (1990).","journal-title":"Br. J. Ophthalmol."},{"key":"68625_CR13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.ophtha.2005.05.026","volume":"112","author":"SM Downes","year":"2005","unstructured":"Downes, S. M. et al. Incidence and natural history of proliferative sickle cell retinopathy: Observations from a cohort study. Ophthalmology 112, 1869\u20131875 (2005).","journal-title":"Ophthalmology"},{"key":"68625_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jfo.2011.10.007","volume":"35","author":"N Leveziel","year":"2012","unstructured":"Leveziel, N. et al. Sickle-cell retinopathy: Retrospective study of 730 patients followed in a referral center. J. Fr. Ophtalmol. 35, 343\u2013347 (2012).","journal-title":"J. Fr. Ophtalmol."},{"key":"68625_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.6.3.16","volume":"6","author":"R Linderman","year":"2017","unstructured":"Linderman, R. et al. Assessing the accuracy of foveal avascular zone measurements using optical coherence tomography angiography: segmentation and scaling. Transl. Vis. Sci. Technol. 6, 16 (2017).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"68625_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0002-9394(71)90429-6","volume":"71","author":"MF Goldberg","year":"1971","unstructured":"Goldberg, M. F. Classification and pathogenesis of proliferative sickle retinopathy. Am. J. Ophthalmol. 71, 649\u2013665 (1971).","journal-title":"Am. J. Ophthalmol."},{"key":"68625_CR17","doi-asserted-by":"publisher","first-page":"e0177059","DOI":"10.1371\/journal.pone.0177059","volume":"12","author":"MR Munk","year":"2017","unstructured":"Munk, M. R. et al. OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devices. PLoS ONE 12, e0177059 (2017).","journal-title":"PLoS ONE"},{"key":"68625_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/bjo.71.7.540","volume":"71","author":"CM Lee","year":"1987","unstructured":"Lee, C. M. et al. Quantification of macular ischaemia in sickle cell retinopathy. Br. J. Ophthalmol. 71, 540\u2013545 (1987).","journal-title":"Br. J. Ophthalmol."},{"key":"68625_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/glia.22956","volume":"64","author":"A Giocanti-Auregan","year":"2016","unstructured":"Giocanti-Auregan, A. et al. Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice. Glia 64, 716\u2013729 (2016).","journal-title":"Glia"},{"key":"68625_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jemt.20829","volume":"73","author":"I Arganda-Carreras","year":"2010","unstructured":"Arganda-Carreras, I., Fern\u00e1ndez-Gonz\u00e1lez, R., Mu\u00f1oz-Barrutia, A. & Ortiz-De-Solorzano, C. 3D reconstruction of histological sections: Application to mammary gland tissue. Microsc. Res. Tech. 73, 1019\u20131029 (2010).","journal-title":"Microsc. Res. Tech."},{"key":"68625_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/2151237X.2007.10129236","volume":"12","author":"D Bradley","year":"2007","unstructured":"Bradley, D., & Roth, G. Adaptive thresholding using the integral image. J. Graph Tools 12, 13\u201321 (2007).","journal-title":"J. Graph Tools"},{"key":"68625_CR22","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1167\/iovs.10-7005","volume":"52","author":"S Tick","year":"2011","unstructured":"Tick, S. et al. Foveal shape and structure in a normal population. Invest. Ophthalmol. Vis. Sci. 52, 5105\u20135110 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"109","key":"68625_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archopht.1991.01080060076029","volume":"1960","author":"RJ Sanders","year":"1991","unstructured":"Sanders, R. J., Brown, G. C., Rosenstein, R. B. & Magargal, L. Foveal avascular zone diameter and sickle cell disease. Arch. Ophthalmol. Chic. Ill 1960(109), 812\u2013815 (1991).","journal-title":"Arch. Ophthalmol. Chic. Ill"},{"key":"68625_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/ICB.0000000000000210","volume":"9","author":"CJ Sanfilippo","year":"2015","unstructured":"Sanfilippo, C. J., Klufas, M. A., Sarraf, D. & Tsui, I. Optical coherence tomography angiography of sickle cell maculopathy. Retin. Cases Brief Rep. 9, 360\u2013362 (2015).","journal-title":"Retin. Cases Brief Rep."},{"key":"68625_CR25","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1364\/BOE.8.004206","volume":"8","author":"M Alam","year":"2017","unstructured":"Alam, M., Thapa, D., Lim, J. I., Cao, D. & Yao, X. Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography. Biomed. Opt. Express 8, 4206\u20134216 (2017).","journal-title":"Biomed. Opt. Express"},{"key":"68625_CR26","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1167\/iovs.16-20045","volume":"57","author":"NA Iafe","year":"2016","unstructured":"Iafe, N. A., Phasukkijwatana, N., Chen, X. & Sarraf, D. Retinal capillary density and foveal avascular zone area are age-dependent: Quantitative analysis using optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 57, 5780\u20135787 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"68625_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware, R. E., de Montalembert, M., Tshilolo, L. & Abboud, M. R. Sickle cell disease. Lancet Lond. Engl. 390, 311\u2013323 (2017).","journal-title":"Lancet Lond. Engl."},{"key":"68625_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0002-9394(74)90454-1","volume":"77","author":"SJ Ryan","year":"1974","unstructured":"Ryan, S. J. Occlusion of the macular capillaries in sickle cell hemoglobin C disease. Am. J. Ophthalmol. 77, 459\u2013461 (1974).","journal-title":"Am. J. Ophthalmol."},{"key":"68625_CR29","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/IAE.0000000000001737","volume":"38","author":"D Seknazi","year":"2018","unstructured":"Seknazi, D. et al. Optical coherence tomography angiography in retinal vein occlusion: Correlations between macular vascular density, visual acuity, and peripheral nonperfusion area on fluorescein angiography. Retina Phila. Pa 38, 1562\u20131570 (2018).","journal-title":"Retina Phila. Pa"},{"key":"68625_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314567","author":"G Lynch","year":"2019","unstructured":"Lynch, G. et al. Foveal avascular zone morphology and parafoveal capillary perfusion in sickle cell retinopathy. Br. J. Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314567 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"68625_CR31","doi-asserted-by":"crossref","unstructured":"Bonnin, S. et al. New insight into the macular deep vascular plexus imaged by optical coherence tomography angiography. Retina (Philadelphia, Pa.) 35(11), 2347\u20132352 (2015).","DOI":"10.1097\/IAE.0000000000000839"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68625-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68625-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:42:59Z","timestamp":1670334179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68625-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68625-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F. Fajnkuchen and A Giocanti-Aur\u00e9gan are consultant for Allergan, Bayer, Novartis and Optos Plc. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11795"}}